Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
smad1xenopus myocardium [+] 

Too many results?Too few results?

Experiment details for smad1

The BMP pathway acts to directly regulate Tbx20 in the developing heart.



Good quality Poor quality
Gene Clone Species Stages Anatomy
smad1.L laevis NF stage 40 myocardium

Display additional annotations [+]
  Fig 5. SMAD1 activation is required for cardiac-specific expression of Tbx20 in X. laevis. (A-F′) Immunohistochemistry of transverse sections through the heart of stage 40 anterior explants shows loss of nuclear phospho-SMAD1/5/8 (arrows) in the myocardium of dorsomorphin-treated explants (D-F,D′-F′) compared with DMSO-treated controls (A-C,A′-C′). In the merged images, anti-phospho-SMAD1/5/8 (pSMAD1/5/8) staining is labeled red, anti-myosin heavy chain (MHC) is labeled green, and nuclei are labeled blue with DAPI. (G-L) In situ hybridization for Tbx20 performed on stage 40 anterior and cardiac explants shows complete loss of Tbx20 expression in the heart (H,L) but not the hindbrain (J) of dorsomorphin-treated anterior and cardiac explants compared with DMSO-treated controls (G,I,K). (M-P) Whole-mount antibody staining of stage 40 anterior explants shows normal expression of the myocardial marker MHC in dorsomorphin-treated explants (N,P) compared to DMSO-treated controls (M,O). Dorso, dorsomorphin. Scale bars: 20 μm in A-F′; 1 mm in G-P.